Identifying Genetic Variants Associated with Opioid Overdose Mortality

识别与阿片类药物过量死亡率相关的遗传变异

基本信息

  • 批准号:
    10597418
  • 负责人:
  • 金额:
    $ 15.75万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2018
  • 资助国家:
    美国
  • 起止时间:
    2018-07-01 至 2024-04-30
  • 项目状态:
    已结题

项目摘要

The CDC has documented the worsening “opioid overdose epidemic” in the U.S. Opioid overdose deaths have increased among males and females, non-Hispanic whites and blacks, and all age groups over age 25.24 Interrelated trends contributing to the epidemic include an increase in prescription opioid overdose deaths spanning more than 15 years and more recent surges in overdose deaths due to illicit opioids (i.e., heroin and fentanyl-related drugs). Overdose deaths involving heroin rose nearly five-fold in the U.S. from 2010 to 2016 while those involving fentanyl and its analogues more than doubled from 2015 to 2016.24,26 Research to improve understanding of the pathophysiology of opioid-induced respiratory depression is thus a public health imperative. Prior genetic research in this area has been limited to candidate gene studies that genotyped a handful of SNPs in samples of very modest size that consisted primarily of European ancestry (EA) individuals. We are proposing to conduct the first GWAS of death due to opioid-induced respiratory depression. Our large EA and African American (AA) sub-samples will each exceed that of the largest prior study by well over an order of magnitude. We will utilize two distinct comparison groups, large previously-genotyped EA and AA samples of opioid dependent individuals and general population members that are well-suited, respectively, to identify effects contingent upon repeated use and those shared with liability of opioid use disorder. Our study design focuses on a definitive outcome measure, death due to opioid-induced respiratory depression, which is expected to provide additional power for our investigation. Many prior studies have examined less clearly demarcated outcomes (clinically observed respiratory depression) in convenience samples (e.g. pediatric surgical patients). This revised proposal is very well-powered to identify common genetic variants in EAs and AAs associated with liability for opioid-induced respiratory depression. We are also proposing to conduct the first examination performed in human opioid overdose decedents of gene expression changes in brain regions involved in opioid-induced respiratory depression including the preBötzinger complex, parabrachial/Kölliker-Fuse nuclei (PB/KF), and raphe nucleus. This complementary investigation will provide additional insight into the pathophysiology underlying this process and enable examination of alterations in gene expression associated with common variants implicated in the GWAS. The specific aims are: 1) To obtain DNA from 15,000 accidental opioid overdose decedents (N’s EA ~10,000; AA ~5000). 2) To conduct a GWAS of opioid-induced respiratory depression including risk shared across opioids, and drug-specific effects, comparing these individuals to two large previously GWAS-genotyped groups of AA and EA individuals: 1) those with opioid use disorder; and 2) those ascertained in general population samples. 3) To examine differential gene expression in the medullary preBötzinger complex and raphe nucleus, and pontine PB/KF nuclei in those who died from accidental opioid overdose (N=50) compared with a matched group of decedents who died from other causes and had negative toxicology screens (N=50) and to relate differential expression in these regions to GWAS data for Aim 2, providing a biological foundation for novel GWAS discoveries.
美国疾病控制与预防中心记录了美国阿片类药物过量的恶化情况

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ARPANA AGRAWAL其他文献

ARPANA AGRAWAL的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ARPANA AGRAWAL', 18)}}的其他基金

7/7 Psychiatric Genomics Consortium: Advancing Discovery and Impact
7/7 精神病学基因组学联盟:推进发现和影响
  • 批准号:
    10376183
  • 财政年份:
    2021
  • 资助金额:
    $ 15.75万
  • 项目类别:
Neurobehavioral pathways of polygenic and polyenvironmental effects on the onset and maintenance of substance involvement
多基因和多环境影响的神经行为途径对物质参与的发生和维持
  • 批准号:
    10317570
  • 财政年份:
    2021
  • 资助金额:
    $ 15.75万
  • 项目类别:
Neurobehavioral pathways of polygenic and polyenvironmental effects on the onset and maintenance of substance involvement
多基因和多环境影响的神经行为途径对物质参与的发生和维持
  • 批准号:
    10487460
  • 财政年份:
    2021
  • 资助金额:
    $ 15.75万
  • 项目类别:
Neurobehavioral pathways of polygenic and polyenvironmental effects on the onset and maintenance of substance involvement
多基因和多环境影响的神经行为途径对物质参与的发生和维持
  • 批准号:
    10656534
  • 财政年份:
    2021
  • 资助金额:
    $ 15.75万
  • 项目类别:
7/7 Psychiatric Genomics Consortium: Advancing Discovery and Impact
7/7 精神病学基因组学联盟:推进发现和影响
  • 批准号:
    10565944
  • 财政年份:
    2021
  • 资助金额:
    $ 15.75万
  • 项目类别:
Prenatal Cannabis Use (PCU) and Development of Offspring Brain and Behavior During Early Life (0-18 Months)
产前大麻使用 (PCU) 与后代大脑和生命早期(0-18 个月)行为的发育
  • 批准号:
    9903265
  • 财政年份:
    2019
  • 资助金额:
    $ 15.75万
  • 项目类别:
Prenatal Cannabis Use (PCU) and Development of Offspring Brain and Behavior During Early Life (0-18 Months)
产前大麻使用 (PCU) 与后代大脑和生命早期(0-18 个月)行为的发育
  • 批准号:
    10347302
  • 财政年份:
    2019
  • 资助金额:
    $ 15.75万
  • 项目类别:
Prenatal Cannabis Use (PCU) and Development of Offspring Brain and Behavior During Early Life (0-18 Months)
产前大麻使用 (PCU) 与后代大脑和生命早期(0-18 个月)行为的发育
  • 批准号:
    10557088
  • 财政年份:
    2019
  • 资助金额:
    $ 15.75万
  • 项目类别:
Prenatal Cannabis Use (PCU) and Development of Offspring Brain and Behavior During Early Life (0-18 Months)
产前大麻使用 (PCU) 与后代大脑和生命早期(0-18 个月)行为的发育
  • 批准号:
    10092992
  • 财政年份:
    2019
  • 资助金额:
    $ 15.75万
  • 项目类别:
Identifying Genetic Variants Associated with Opioid Overdose Mortality
识别与阿片类药物过量死亡率相关的遗传变异
  • 批准号:
    10162576
  • 财政年份:
    2018
  • 资助金额:
    $ 15.75万
  • 项目类别:

相似海外基金

Drug Abuse and Crime Across the Life Course in an African American Population
非裔美国人一生中的药物滥用和犯罪
  • 批准号:
    8013895
  • 财政年份:
    2008
  • 资助金额:
    $ 15.75万
  • 项目类别:
Drug Abuse and Crime Across the Life Course in an African American Population
非裔美国人一生中的药物滥用和犯罪
  • 批准号:
    7462657
  • 财政年份:
    2008
  • 资助金额:
    $ 15.75万
  • 项目类别:
Drug Abuse and Crime Across the Life Course in an African American Population
非裔美国人一生中的药物滥用和犯罪
  • 批准号:
    7755368
  • 财政年份:
    2008
  • 资助金额:
    $ 15.75万
  • 项目类别:
Drug Abuse and Crime Across the Life Course in an African American Population
非裔美国人一生中的药物滥用和犯罪
  • 批准号:
    7586197
  • 财政年份:
    2008
  • 资助金额:
    $ 15.75万
  • 项目类别:
Molecular and Genetic Signatures of Perturbed Diabetic Pathways with Hepatitis C Virus infection and Co-morbidity Risks in African American Population
丙型肝炎病毒感染引起的糖尿病通路紊乱的分子和遗传特征以及非洲裔美国人的共病风险
  • 批准号:
    10132461
  • 财政年份:
    1997
  • 资助金额:
    $ 15.75万
  • 项目类别:
Molecular and Genetic Signatures of Perturbed Diabetic Pathways with Hepatitis C Virus infection and Co-morbidity Risks in African American Population
丙型肝炎病毒感染引起的糖尿病通路紊乱的分子和遗传特征以及非洲裔美国人的共病风险
  • 批准号:
    10331060
  • 财政年份:
    1997
  • 资助金额:
    $ 15.75万
  • 项目类别:
Molecular and Genetic Signatures of Perturbed Diabetic Pathways with Hepatitis C Virus infection and Co-morbidity Risks in African American Population
丙型肝炎病毒感染引起的糖尿病通路紊乱的分子和遗传特征以及非洲裔美国人的共病风险
  • 批准号:
    10597891
  • 财政年份:
    1997
  • 资助金额:
    $ 15.75万
  • 项目类别:
Molecular and Genetic Signatures of Perturbed Diabetic Pathways with Hepatitis C Virus infection and Co-morbidity Risks in African American Population
丙型肝炎病毒感染引起的糖尿病通路紊乱的分子和遗传特征以及非洲裔美国人的共病风险
  • 批准号:
    10178913
  • 财政年份:
    1997
  • 资助金额:
    $ 15.75万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了